Wegovy (Semaglutide): Wegovy was approved by the FDA in 2021
Data on GLP-1 utilization were retrieved from electronic medical records from 20132023, while information on smoking behaviours was obtained through a structured questionnaire developed for this study and distributed from May to August 2024
Data mapping In the REAC files, the FAERS database defines adverse events using PTs from the Medical Dictionary for Regulatory Activities (MedDRA v23.1)
Citrus, bell bell pepper and kiwi score high
Materials and methods Animals, adaptations and grouping The experimental procedure was evaluated by an ethical committee and approved by the State Office for Agriculture, Food Safety and Fisheries Mecklenburg-Vorpommern, Germany (LALLF 7221.3-1-052/17)
[4] Ultimately, the choice of GLP-1 agonist should be a collaborative decision between the patient and their healthcare provider, taking into account individual factors, treatment goals, and potential risks and benefits